Company / Depreciation & Amortization
LeMaitre Vascular Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$10.4M
FY2025
5-year range
$5.4M / $10.4M
FY2021-FY2025
Trend
+8.4%
vs FY2024
Sector context
#114 of 141
Health Care
What the data says
LeMaitre Vascular's depreciation & amortization of $10M is lower than 81% of companies in the Health Care sector (FY2025). Depreciation & Amortization has increased for 8 consecutive years, from $3M in FY2017 to $10M in FY2025.
Based on SEC 10-K filings.
$10M in FY2025 with a 5-year CAGR of +19.2%.
Increased from $10M to $10M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +7.5%
- 5-Year CAGR
- +19.2%
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 141This company $10.4M Sector average $344.6M
▼
-97.0% below sector average
Key checks
Key Insights
- LeMaitre Vascular's depreciation & amortization has grown for 8 consecutive years.
- 5-year CAGR of +19.2%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 8.4% year-over-year.
- Ranks #114 out of 141 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.4M | +8.4% |
| FY2024 | $9.6M | +1.0% |
| FY2023 | $9.5M | +13.3% |
| FY2022 | $8.4M | +55.0% |
| FY2021 | $5.4M | +25.3% |
| FY2020 | $4.3M | +6.6% |
| FY2019 | $4.1M | +12.9% |
| FY2018 | $3.6M | +5.8% |
| FY2017 | $3.4M | -5.5% |
| FY2016 | $3.6M | +28.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026